Treatment-resistant depression (TRD) is a condition that affects millions of people worldwide. Despite the availability of antidepressant medications, approximately one-third of patients who have been diagnosed with depression suffer from TRD. Fortunately, there is new hope for those who have not responded well to traditional antidepressant treatments - Spravato. At Sulcata Psychiatry, we specialize in helping patients find the right treatment plan for their needs.
How Spravato Can Treat Your Treatment-Resistant Depression
FDA-Approved For Adults With TRD
Spravato, also known as Eesketamine, is a nasal spray medication that works by altering the levels of neurotransmitters in the brain. It is the first and only FDA-approved medicine for TRD in adults who have failed at least two other antidepressants. The drug has been found to be effective in improving symptoms of depression within just hours of the first dose.
Fast-Acting Relief
Unlike traditional antidepressants, which can take weeks or even months to show any results, Spravato works quickly to deliver relief to patients suffering from TRD. In clinical trials, patients saw significant improvement in their symptoms after just four weeks of treatment.
Careful Administration of Spravato
Spravato is administered under the supervision of a healthcare professional in a clinical setting, as it is a controlled substance due to its potential for abuse and misuse. The medication is designed to be taken in conjunction with an oral antidepressant to provide a more comprehensive treatment plan.
Is Spravato Right For You?
It is important to note that Spravato is not for everyone. Patients with a history of addiction or abuse, as well as those with severe liver or blood vessel problems, may not be eligible for this treatment. Hence, it's crucial to consult with your healthcare provider to determine if Spravato is the right option for you.
Spravato brings newfound hope to patients who don’t get relief from traditional antidepressants. With its fast-acting effects, it is a promising breakthrough in treating TRD. At Sulcata Psychiatry, we understand that TRD can be a challenging and frustrating condition to live with. That's why we are committed to staying up-to-date with the newest treatment options, like Spravato, to provide our patients with hope and relief. In your next appointment, ask us about the possibility of using Spravato. Contact us today to schedule an appointment.